Louria Hayon Igal bought RAPH

November 20, 2025 · Form 4 insider transaction

Louria Hayon Igal bought 350,000 shares of Raphael Pharmaceutical Inc. at $0.01 per share, a transaction worth $3.5K. The trade was recorded as exercise of in-the-money option and disclosed on an SEC Form 4, filed 137 days after the transaction.